000			02044 a2200577 4500
005			20250515084203.0
264		0	_c20080116
008			200801s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdm346 _2doi
040			_aNLM _beng _cNLM
100	1		_aSpecenier, P M
245	0	0	_aPhase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cNov 2007
300			_a1856-60 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aCarcinoma, Squamous Cell _xmortality
650	0	4	_aCombined Modality Therapy
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aFeasibility Studies
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHead and Neck Neoplasms _xmortality
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Invasiveness _xpathology
650	0	4	_aNeoplasm Staging
650	0	4	_aRadiotherapy Dosage
650	0	4	_aRadiotherapy, Adjuvant
650	0	4	_aRisk Assessment
650	0	4	_aSurvival Analysis
650	0	4	_aTime Factors
650	0	4	_aGemcitabine
700	1		_aVan den Weyngaert, D
700	1		_aVan Laer, C
700	1		_aWeyler, J
700	1		_aVan den Brande, J
700	1		_aHuizing, M T
700	1		_aDyck, J
700	1		_aSchrijvers, D
700	1		_aVermorken, J B
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 18 _gno. 11 _gp. 1856-60
856	4	0	_uhttps://doi.org/10.1093/annonc/mdm346 _zAvailable from publisher's website
999			_c17351790 _d17351790